Angiodynamics (ANGO) Return on Capital Employed (2011 - 2026)
Angiodynamics (ANGO) posted Return on Capital Employed of 21.1% for Q2 2026, down 18.29% on a QoQ basis from 17.84% in Q1 2026, and down 176.0% year-over-year from 27.77% in Q2 2025.
Angiodynamics (ANGO) Return on Capital Employed (2011 - 2026) Analysis & Trends
Angiodynamics' Return on Capital Employed history runs 16 years deep, the most recent figure standing at 21.1% for Q2 2026.
- Quarterly Return on Capital Employed fell 176.0% year-over-year to 21.1% in Q2 2026, while the trailing twelve-month figure through May 2026 was 21.1% (down 176.0% YoY) and the FY2026 annual result came in at 20.07%, down 213.0% from the prior year.
- Return on Capital Employed was 21.1% for Q2 2026 at Angiodynamics, down from 17.84% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 0.63% in Q3 2023 and bottomed at 116.94% in Q4 2024.
- A 5-year average of 29.6% and a median of 17.23% in 2025 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2024 — Return on Capital Employed tumbled 11507 bps — and 2025, when it soared 10031 bps.
- Angiodynamics' Return on Capital Employed stood at 6.84% in 2022, then soared by 73 bps to 1.88% in 2023, then sank by 6134 bps to 116.94% in 2024, then soared by 86 bps to 16.63% in 2025, then slipped by 27 bps to 21.1% in 2026.
- Business Quant data shows ANGO's Return on Capital Employed at 21.1% in Q2 2026, 17.84% in Q1 2026, and 16.63% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 28.56% |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 18.58% |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 5.02% |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | - |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 25.95% |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 19.71% |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 4.68% |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 19.44% |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 12.74% |
| 10 | Angiodynamics | 558.11 Mn | 504.25 Mn | 46.77 Mn | -21.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -21.10% |
| Feb 28, 2026 | -17.84% |
| Nov 30, 2025 | -16.63% |
| Aug 31, 2025 | -18.33% |
| May 31, 2025 | -19.34% |
| Feb 28, 2025 | -23.09% |
| Nov 30, 2024 | -116.94% |
| Aug 31, 2024 | -105.08% |
| May 31, 2024 | -83.63% |
| Feb 29, 2024 | -60.92% |
| Nov 30, 2023 | -1.88% |
| Aug 31, 2023 | -0.63% |
| May 31, 2023 | -11.28% |
| Feb 28, 2023 | -7.64% |
| Nov 30, 2022 | -6.84% |
| Aug 31, 2022 | -6.89% |
| May 31, 2022 | -6.01% |
| Feb 28, 2022 | -8.74% |
| Nov 30, 2021 | -8.41% |
| Aug 31, 2021 | -7.55% |